Lipocine, Inc. (LPCN)
1.90
-0.04
(-2.06%)
USD |
NASDAQ |
Apr 07, 10:27
Lipocine EPS Diluted (Quarterly) : -0.4158 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -1.858 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.370M |
| Revenue (Quarterly) | 1.145M |
| Total Expenses (Quarterly) | 3.516M |
| Enterprise Value | -0.769M |
| Gross Profit Margin (Quarterly) | 98.69% |
| Profit Margin (Quarterly) | -206.9% |
| Earnings Yield | -98.18% |
| Normalized Earnings Yield | -98.18 |